about
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase I, Study in Chinese NSCLC Patients
@en
type
label
Phase I, Study in Chinese NSCLC Patients
@en
prefLabel
Phase I, Study in Chinese NSCLC Patients
@en
P1476
Phase I, Open-Label, Two Parts ...... yrosine Kinase Inhibitor Agent
@en
P1813
AURAChinaPK
@en
P3098
NCT02529995
P4844
P580
2015-08-24T00:00:00Z
P582
2016-01-28T00:00:00Z